Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RETA | PCVX | APLS | ||
Company | Reata Pharma | Vaxcyte Inc | Apellis Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 172.34 | 61.07 | 48.98 | ||
High | 172.46 | 62.28 | 49.38 | ||
Low | 172.32 | 60.72 | 47.56 | ||
Last | 172.36 | 61.03 | 47.84 | ||
Change | +0.04 | +0.31 | -2.02 | ||
% Change | +0.02% | +0.51% | -4.05% | ||
Volume | 1,988,500 | 500,600 | 1,400,600 | ||
20-Day Average Volume | 810,510 | 723,225 | 1,229,155 | ||
Previous Close | 172.32 | 60.72 | 49.86 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 170.84 | 62.39 | 51.81 | ||
20-Day Raw Stochastic | 97.36% | 36.49% | 11.89% | ||
20-Day Relative Strength | 81.56% | 40.70% | 37.73% | ||
Weighted Alpha | +177.60 | +17.63 | -19.34 | ||
Today's Opinion | 100% Buy | 8% Buy | 40% Sell | ||
Previous Opinion | 100% Buy | 8% Buy | 40% Sell | ||
Last Month's Opinion | 100% Buy | 40% Buy | 8% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.18% since 09/18/23 | -0.93% since 04/22/24 | +0.42% since 04/22/24 | ||
Low | 171.96 on 09/19/23 | 58.10 on 04/25/24 | 47.02 on 04/25/24 | ||
High | 172.46 on 09/25/23 | 62.56 on 04/23/24 | 50.98 on 04/26/24 | ||
1-Month | |||||
%Chg | +1.99% since 08/25/23 | -10.66% since 03/28/24 | -18.61% since 03/28/24 | ||
Low | 168.67 on 09/05/23 | 58.10 on 04/25/24 | 46.40 on 04/18/24 | ||
High | 172.46 on 09/25/23 | 68.10 on 04/01/24 | 59.91 on 04/01/24 | ||
3-Month | |||||
%Chg | +83.77% since 06/23/23 | -10.91% since 01/29/24 | -26.81% since 01/29/24 | ||
Low | 88.80 on 06/27/23 | 58.10 on 04/25/24 | 46.40 on 04/18/24 | ||
High | 172.46 on 09/25/23 | 82.04 on 02/28/24 | 71.90 on 02/26/24 | ||
6-Month | |||||
%Chg | +101.14% since 03/24/23 | +29.85% since 10/27/23 | +0.63% since 10/27/23 | ||
Low | 76.54 on 05/10/23 | 46.16 on 11/13/23 | 41.19 on 11/06/23 | ||
High | 172.46 on 09/25/23 | 82.04 on 02/28/24 | 73.80 on 01/09/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 6,575,535 | 6,603,847 | 6,012,219 | ||
Shares Outstanding, K | 38,150 | 108,759 | 120,582 | ||
Annual Sales | 2,220,000 | 0 | 396,590,000 | ||
Annual Net Income | -311,900,000 | -402,270,000 | -528,630,000 | ||
Last Quarter Sales | 22,750,000 | 0 | 146,380,000 | ||
Last Quarter Net Income | 193,000,000 | -180,800,000 | -88,580,000 | ||
60-Month Beta | 1.42 | 0.89 | 0.88 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.32 on 08/08/23 | -1.82 on 02/27/24 | -0.73 on 02/27/24 | ||
Latest Earnings Date | 11/14/23 | 05/13/24 | 05/07/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |